Attached files

file filename
8-K - 8-K - METLIFE INCd707756d8k.htm
EX-5.1 - EX-5.1 - METLIFE INCd707756dex51.htm
EX-4.1 - EX-4.1 - METLIFE INCd707756dex41.htm
EX-1.1 - EX-1.1 - METLIFE INCd707756dex11.htm

Exhibit 1.2

PRICING AGREEMENT

April 7, 2014

Merrill Lynch, Pierce, Fenner & Smith

Incorporated

Barclays Capital Inc.

Deutsche Bank Securities Inc.

J.P. Morgan Securities LLC

Morgan Stanley & Co. LLC

As Representatives of the several Underwriters

named in Schedule I hereto

c/o Merrill Lynch, Pierce, Fenner & Smith

 Incorporated

One Bryant Park

New York, New York 10036

c/o Barclays Capital Inc.

745 Seventh Avenue

New York, New York 10019

c/o Deutsche Bank Securities Inc.

60 Wall Street

New York, New York 10005

c/o J.P. Morgan Securities LLC

383 Madison Avenue

New York, New York 10179

c/o Morgan Stanley & Co. LLC

1585 Broadway

New York, New York 10036

Ladies and Gentlemen:

MetLife, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein (this “Agreement”) and in the Underwriting Agreement, dated April 7, 2014 (the “Underwriting Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the Securities specified in Schedule II hereto (the “Underwritten Securities”).

 

1


Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Agreement, the Applicable Time and the Closing Date. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Each reference to Securities Agreement shall be deemed to refer to the Indenture, dated as of November 9, 2001 between MetLife, Inc. and Bank One Trust Company, N.A. (predecessor to The Bank of New York Mellon Trust Company, National Association) (the “Senior Indenture”) and the Twenty-Fifth Supplemental Indenture to be dated April 10, 2014, between MetLife, Inc. and The Bank of New York Mellon Trust Company, National Association. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herein as therein defined. The Representatives designated to act on behalf of the Underwriters of the Securities pursuant to the Underwriting Agreement are designated as the “Joint Book-Running Managers” at the end of Schedule II hereto.

Subject to the terms and conditions set forth herein and in the Underwriting Agreement incorporated herein by reference, the Company agrees to issue, sell and deliver to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at the time and at the purchase price to the Underwriters set forth in Schedule III hereto, the principal amount of Securities set forth opposite the name of such Underwriter in Schedule I hereto.

If the foregoing is in accordance with your understanding, please sign and return to us counterparts hereof, and upon acceptance hereof by you, on behalf of each of the Underwriters, this letter and such acceptance hereof, including the provisions of the Underwriting Agreement incorporated herein by reference, shall constitute a binding agreement between each of the Underwriters and the Company. It is understood that your acceptance of this letter on behalf of each of the Underwriters is or will be pursuant to the authority set forth in a form of Agreement among Underwriters, the form of which shall be submitted to the Company for examination upon request, but without warranty on the part of the Representatives as to the authority of the signers thereof.

[Signature pages follow]

 

2


Very truly yours,
METLIFE, INC.
By:  

/s/ Marlene B. Debel

  Name:   Marlene B. Debel
  Title:   Senior Vice President and Treasurer


Accepted as of the date hereof
on behalf of each of the Underwriters:
MERRILL LYNCH, PIERCE, FENNER & SMITH                               INCORPORATED
By:  

/s/ Matthew Basler

  Name:   Matthew Basler
  Title:   Managing Director

[Signature page to Senior Notes Pricing Agreement]


BARCLAYS CAPITAL INC.
By:  

/s/ Travis H. Barnes

  Name:   Travis H. Barnes
  Title:   Managing Director

 

[Signature page to Senior Notes Pricing Agreement]


DEUTSCHE BANK SECURITIES INC.
By:  

/s/ Mary Hardgrove

  Name:   Mary Hardgrove
  Title:   Managing Director
By:  

/s/ Adam Raucher

  Name:   Adam Raucher
  Title:   Director

 

[Signature page to Senior Notes Pricing Agreement]


J.P. MORGAN SECURITIES LLC
By:  

/s/ Som Bhattacharyya

  Name:   Som Bhattacharyya
  Title:   Vice President

 

[Signature page to Senior Notes Pricing Agreement]


MORGAN STANLEY & CO. LLC
By:  

/s/ Yurij Slyz

  Name:   Yurij Slyz
  Title:   Executive Director

 

[Signature page to Senior Notes Pricing Agreement]


SCHEDULE I

TO PRICING AGREEMENT

 

Underwriters    Principal Amount
of $1,000,000,000
3.600% Senior
Notes due 2024 to
be Purchased
 

Merrill Lynch, Pierce, Fenner & Smith

                      Incorporated

   $ 170,000,000   

Barclays Capital Inc.

     170,000,000   

Deutsche Bank Securities Inc.

     170,000,000   

J.P. Morgan Securities LLC

     170,000,000   

Morgan Stanley & Co. LLC

     170,000,000   

BNP Paribas Securities Corp.

     30,000,000   

HSBC Securities (USA) Inc.

     30,000,000   

Mizuho Securities USA Inc.

     30,000,000   

SMBC Nikko Securities America, Inc.

     30,000,000   

U.S. Bancorp Investments, Inc.

     30,000,000   
  

 

 

 

Total

   $ 1,000,000,000   

 

[Signature page to Senior Notes Pricing Agreement]


SCHEDULE II

TO PRICING AGREEMENT

Filed pursuant to Rule 433

April 7, 2014

Relating to

Preliminary Prospectus Supplement dated April 7, 2014 to

Prospectus dated November 15, 2013

Registration Statement No. 333-192366

 

LOGO

MetLife, Inc.

$1,000,000,000 3.600% Senior Notes due 2024

Final Term Sheet

April 7, 2014

 

Issuer:   MetLife, Inc. (“Issuer”)
Securities:   3.600% Senior Notes due 2024
Aggregate Principal Amount:   $1,000,000,000
Price to the Public:   99.992% of principal amount plus accrued interest, if any, from April 10, 2014
Gross Underwriting Discount:   0.45%
Proceeds to Issuer Before Expenses:   $995,420,000
Maturity Date:   April 10, 2024
Pricing Date:   April 7, 2014
Settlement Date:   April 10, 2014
Interest Payment Dates:   Semi-annually on April 10 and October 10 of each year

 

SII-1


First Interest Payment Date:   October 10, 2014
Coupon:   3.600%
Benchmark Treasury:   UST 2.75% due February 15, 2024
Spread to Benchmark Treasury:   T + 90 bps
Benchmark Treasury Price and Yield:   100-13+; 2.701%
Yield to Maturity:   3.601%
Denominations:   $2,000 and integral multiples of $1,000 in excess thereof
Ranking:   Senior Unsecured
Redemption:   The Senior Notes will be redeemable at MetLife, Inc.’s option, in whole or in part, at any time and from time to time at a redemption price equal to the greater of 100% of the principal amount to be redeemed plus accrued and unpaid interest to, but excluding, the date fixed for redemption and the Make-Whole Redemption Amount calculated as described in the preliminary prospectus supplement at the rate of T + 15 bps.
CUSIP/ISIN:   59156R BH0 / US59156RBH03
Joint Book-Running Managers:  

Merrill Lynch, Pierce, Fenner & Smith

                     Incorporated

Barclays Capital Inc.

Deutsche Bank Securities Inc.

J.P. Morgan Securities LLC

Morgan Stanley & Co. LLC

Co-Managers:  

BNP Paribas Securities Corp.

HSBC Securities (USA) Inc.

Mizuho Securities USA Inc.

SMBC Nikko Securities America, Inc.

U.S. Bancorp Investments, Inc.

 

SII-2


The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Merrill Lynch, Pierce, Fenner & Smith Incorporated toll free at (800) 294-1322, Barclays Capital Inc. toll free at (888) 603-5847, Deutsche Bank Securities Inc. toll free at (800) 503-4611, J.P. Morgan Securities LLC collect at (212) 834-4533, or Morgan Stanley & Co. LLC at (866) 718-1649.

 

SII-3


SCHEDULE III

TO PRICING AGREEMENT

Underwriters Purchase Price of 3.600% Senior Notes due 2024: 99.542% of the principal amount thereof

Closing Date: April 10, 2014

Addresses for Notices, etc. to the Representatives:

Merrill Lynch, Pierce, Fenner & Smith

Incorporated

50 Rockefeller Plaza, NY1-050-12-01

New York, NY 10020

Attention: High Grade Debt Capital Markets Transaction Management/Legal

Fax: (212) 901-7881

Barclays Capital Inc.

745 Seventh Avenue

New York, New York 10019

Attention: Syndicate Registration

Fax: (646) 834-8133

Deutsche Bank Securities Inc.

60 Wall Street

New York, New York 10005

Attention: Debt Capital Markets Syndicate

Fax: (212) 797-2202, with a copy to General Counsel, Fax: (212) 797-4561

J.P. Morgan Securities LLC

383 Madison Avenue

New York, New York 10179

Attention: Investment Grade Syndicate Desk – 3rd Floor

Fax: (212) 834-6081

Morgan Stanley & Co. LLC

1585 Broadway

New York, New York 10036

Attention: Investment Banking Division

Fax: (212) 507-8999

 

VI-1